approval · primary record
ZILGANERSEN SODIUM
FDA · NDA · 2026-09-03
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-09-03 |
| Brand | ZANVASTRO |
| Sponsor | IONIS PHARMS INC |
| Route | INTRATHECAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:06.930Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ZILGANERSEN SODIUM:2026-09-03
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zilganersen Sodium · compound